Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05777200
Collaborator
(none)
200
13

Study Details

Study Description

Brief Summary

Substance use disorder (SUD) is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms.

Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs.

This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Supportive psychotherapy

Detailed Description

Substance use disorder (SUD) is a complex condition in which there is uncontrolled use of a substance despite its harmful consequences. People with SUD have an intense focus on using a certain substance(s) such as alcohol, tobacco, or illicit drugs, to the point where the person's ability to function in day-to-day life becomes impaired. People keep using the substance even when they know it is causing or will cause problems.

Drug use brings with it the likelihood of several negative health consequences. These can include a wide range of physical and mental health disorders, foremost of which are dependence, HIV infection, hepatitis-related liver diseases, overdose and premature death.

The problem of substance use is becoming one of the most serious and rapidly growing phenomena all over the world. It accounts for substantial global morbidity, mortality, and financial and social burden. According to Global Burden of Disease (GBD) study, there were an estimated 494,000 drug-related deaths attributable to the use of drugs in 2019.

In 2020, 1 in every 18 people aged 15-64 worldwide - an estimated 284 million people (5.6 per cent of the population) - had used a drug in the past 12 months. However, the coverage of interventions for the treatment of drug use disorders remains low overall. Implementation of scientific evidence-based drug prevention interventions remains low as well, especially in middle- and low-income countries.

In Egypt, SUD is a serious public health threat. Recent studies have demonstrated increases in the prevalence of the use of tobacco, illegal drugs, and over-the-counter drugs, particularly among youth.

Drug treatment registers are often used as a proxy indicator of treatment demand. This information is useful for analysis of service utilization and can be used as an indicator of trends in prevalence and patterns of high-risk drug consumption.

Assiut University Hospital is the biggest hospital in Upper Egypt, and it provides health services for Assiut city and most of the neighboring governorates. Addiction management unit of Assiut University Hospital contains 16 beds, based on paid service and about 400 patients have been admitted per year.

SUD is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms.

Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs.

This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit of Assiut University Hospital
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Mar 31, 2024
Anticipated Study Completion Date :
May 1, 2024

Outcome Measures

Primary Outcome Measures

  1. To identify the sociodemographic characteristics of patients with substance use disorder attending addiction treatment unit. [One week]

    Sociodemographic characteristics with a special prepared survey that includes: Personal information, and socioeconomic status.(Age, gender, marital status, work, income, educational level, ...etc) Previous admissions/trials for detox.(number of previous admissions/trials detox, where they were, maximum abstinence time, and the withdrawal symptoms the patient had) Medical, psychological, social, financial, and legal aspects of addiction. Adverse life events dating before starting addiction. Detailed description of substance(s) used.( Substances used, doses, route of administration, when, where, and with whom he prefers taking the drug) Psychiatric interview.

  2. To identify personality traits of patients with substance use disorder attending addiction treatment unit. [One week]

    Data about personality traits of patients with substance use disorder will be obtained through: Psychiatric interview. The Symptom Checklist-90-Revised (SCL-90-R). The Five-Factor Model of Personality.

  3. To identify patterns of substance abuse among patients with substance use disorder attending addiction treatment unit. [One week]

    Data about patterns of substance abuse will be gathered through: Psychiatric interview. Severity of Dependence Scale (SDS). Urine Drug Screen.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients with substance use disorder who are admitted to the addiction treatment unit.

  • Accept participating into the study.

Exclusion Criteria:
  • Patients refuse participating in the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Study Chair: Alaa El Din M. Darweesh, Prof., Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University
  • Study Director: Romany H. Gabra, Dr, Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Mena Fahy Rizq Farag, Resident of Neurology and Psychiatry, Assiut University Hospital, Assiut University
ClinicalTrials.gov Identifier:
NCT05777200
Other Study ID Numbers:
  • Substance-use disorder
First Posted:
Mar 21, 2023
Last Update Posted:
Mar 21, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mena Fahy Rizq Farag, Resident of Neurology and Psychiatry, Assiut University Hospital, Assiut University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2023